Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers
Journal article published in 2020 by
Filip Janku 
,
Divya Sakamuri,
Shumei Kato ,
Helen J. Huang,
S. Greg Call,
Aung Naing,
Veronica R. Holley,
Sapna P. Patel ,
Rodabe N. Amaria,
Gerald S. Falchook,
Sarina A. Piha‐Paul ,
Ralph G. Zinner,
Apostolia M. Tsimberidou ,
David S. Hong,
Funda Meric‐Bernstam
,
Divya Sakamuri,
Shumei Kato ,
Helen J. Huang,
S. Greg Call,
Aung Naing,
Veronica R. Holley,
Sapna P. Patel ,
Rodabe N. Amaria,
Gerald S. Falchook,
Sarina A. Piha‐Paul ,
Ralph G. Zinner,
Apostolia M. Tsimberidou ,
David S. Hong,
Funda Meric‐Bernstam
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 